Beth A. Davison

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

Alexandre Mebazaa, Beth A. Davison, Ovidiu Chioncel et al. · The Lancet · 2022 · 1K citations · Full text

Medicine, Cardiology, Internal Medicine +10

Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial

John R. Teerlink, Gad Cotter, Beth A. Davison et al. · The Lancet · 2012 · 908 citations

Medicine, Cardiology, Pharmacology +11

The Causes, Treatment, and Outcome of Acute Heart Failure in 1006 Africans From 9 Countries

Albertino Damasceno, Bongani M. Mayosi, Mahmoud U. Sani et al. · Archives of Internal Medicine · 2012 · 532 citations · Full text

Medicine, Cardiology, Internal Medicine +12

Is Worsening Renal Function an Ominous Prognostic Sign in Patients With Acute Heart Failure?

Marco Metra, Beth A. Davison, Luca Bettari et al. · Circulation Heart Failure · 2011 · 477 citations

Medicine, Cardiology, Internal Medicine +16

Suboptimal reliability of liver biopsy evaluation has implications for randomized clinical trials

Beth A. Davison, Stephen A. Harrison, Gad Cotter et al. · Journal of Hepatology · 2020 · 427 citations

Medicine, Internal Medicine, Hepatology +12